VANTA BIOSCIENCE Fact Sheet, VANTA BIOSCIENCE Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

VANTA BIOSCIENCE Fact Sheet    (VANB)


FREE REPLAY: Discover What Richa Revealed in Her Smallcaps Summit


Here is the latest financial fact sheet of VANTA BIOSCIENCE. For more details, see the VANTA BIOSCIENCE quarterly results and VANTA BIOSCIENCE share price and chart. For a sector overview, read our pharmaceuticals sector report.

VANTA BIOSCIENCE Price History

Price Rs 105.9
Mkt Cap Rs m 668
Vol '000 0.8
P/E X  
P/CF X 30.4
EPS (TTM) Rs 0.0
% ch % 0.9
No. of shares m 6.31
% ch week % 0.0
% ch 1-mth % -12.9
% ch 12-mth % -23.1
52 week H/L Rs 195.5/105.0
(As on Nov 25, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

VANTA BIOSCIENCE Financials

No. of Mths
Year Ending
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
5-Yr Chart
Click to enlarge
VANTA BIOSCIENCE EQUITY SHARE DATA
High RsNA74153195 
Low RsNA414680 
Sales per share (Unadj.) Rs06.618.621.2 
Earnings per share (Unadj.) Rs001.11.6 
Diluted earnings per shareRs0.00.01.11.6 
Cash flow per share (Unadj.) Rs01.02.23.5 
Dividends per share (Unadj.) Rs0000 
Adj. dividends per shareRs0.000.000.000.00 
Avg Dividend yield %NM000 
Book value per share (Unadj.) Rs16.828.935.337.2 
Adj. book value per shareRs9.726.335.237.2 
Shares outstanding (eoy) m3.655.736.316.31 
Bonus / Rights / Conversions  ---- 
Price / Sales ratio xNM8.85.46.5 
Avg P/E ratio xNM1,217.190.085.7 
P/CF ratio (eoy) xNM55.344.639.4 
Price / Book Value ratio x02.02.83.7 
Dividend payout %NM000 
Avg Mkt Cap Rs m0332628868 
No. of employees `000NANANANA 
Total wages/salary Rs m0162939 
Avg. sales/employee Rs ThNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNM 
VANTA BIOSCIENCE INCOME DATA
Net Sales Rs m038117134 
Other income Rs m0121 
Total revenues Rs m038120135 
Gross profit Rs m0103344 
Depreciation Rs m06712 
Interest Rs m021719 
Profit before tax Rs m031113 
Minority Interest Rs m0000 
Prior Period Items Rs m0000 
Extraordinary Inc (Exp) Rs m0000 
Tax Rs m0343 
Profit after tax Rs m00710 
Gross profit margin %NM27.427.932.7 
Effective tax rate %NM91.336.724.5 
Net profit margin %NM0.75.97.6 
VANTA BIOSCIENCE BALANCE SHEET DATA
Current assets Rs m590172200 
Current liabilities Rs m12433100 
Net working cap to sales %NM175.5118.074.6 
Current ratio x5.53.85.22.0 
Inventory Days DaysNM4707226 
Debtors Days DaysNM324938 
Net fixed assets Rs m132202219287 
Share capital Rs m36576363 
"Free" reserves Rs m25109159172 
Net worth Rs m62166222235 
Long term debt Rs m75100122137 
Total assets Rs m137292391487 
Interest coverage xNM2.61.71.7 
Debt to equity ratio x1.20.60.50.6 
Sales to assets ratio x00.10.30.3 
Return on assets %00.86.16.1 
Return on equity %00.23.14.3 
Return on capital %01.98.18.9 
Exports to sales %NM11.632.051.4 
Imports to sales %NM29.610.80.8 
Exports (fob) Rs m043869 
Imports (cif) Rs m011131 
Fx inflow Rs m043869 
Fx outflow Rs m22,47412143 
Net fx Rs m-22,474-72465 
VANTA BIOSCIENCE CASH FLOW
From Operations Rs m -3 -68 -10 23 
From Investments Rs m -129 -75 -55 -74 
From Financial Activity Rs m 137 139 97 19 
Net Cashflow Rs m 4 -4 32 -31 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 69.0%
Institution 0.0%
Non-Institution 31.0%
Total 100.0%
Free Float 31.0%
Pledged promoter holdings 0.0%
 

Company Information

REGD OFF No.02/ G/308/ G No.3/ F F/ S F/1-20-248 , Umajay Complex, Rasoolpura Secunderabad, Hyderabad - 500003
E-MAIL cs@vantabio.com WEB www.vantabio.com
TEL 040-6657 5454 FAX 040-2790 8708
SECTOR MISCELLANEOUS GROUP Private sector
TR AGENT Bigshare Services Pvt Ltd, 306 Right Wing Amrutha Ville Opp. Yasodha Hospital, Raj Bhavan Road, Somajiguda
YEAR OF INC: 2016 BSE CODE: 540729 FV (Rs): 10 DIV YIELD (%): -

More Miscellaneous Company Fact Sheets:   AMI ORGANICS  ZENITH HEALTH  GODAVARI DRU  RUBRA MEDICA  MARKSANS PHARMA.  

Compare VANTA BIOSCIENCE With:   AMI ORGANICS  ZENITH HEALTH  GODAVARI DRU  RUBRA MEDICA  MARKSANS PHARMA.  




Today's Market

Bloodbath on Dalal Street: 6 Reasons Why Sensex Slumped 1,688 Points Today(Closing)

Indian share markets witnessed negative trading activity throughout the day today and ended deep in the red.

Views on news

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

More Views on News

Most Popular

Infosys vs TCS: Which is Better? (Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake (Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

How to Hit Rs 100 Crore Wealth in Your Lifetime (Equitymaster Wealth)

Nov 15, 2021

This is how you can achieve the ambitious goal of a net worth of Rs 100 crore.

Don't Sell these Stocks if the Market Falls (Profit Hunter)

Nov 17, 2021

These are the 3 types of stocks that you should not sell in a market crash.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing. (Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK VANTA BIOSCIENCE

  • Track your investment in VANTA BIOSCIENCE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON VANTA BIOSCIENCE

VANTA BIOSCIENCE - W.H.BRADY COMPARISON

COMPARE VANTA BIOSCIENCE WITH

MARKET STATS